Search Results
31 results found for "Septerna"
Posts (27)
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
February 2022 Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with pioneer as co-founder "Jan 27, 2022 07:00am Septerna wants to spark a second golden age in G-protein-coupled
- New Podcast, Sweet Structures & $2.2B GPCR Moves
GPCRs, the membrane-driven modulation of mGluR2, and a big headline, Novo Nordisk’s $2.2B deal with Septerna
- New Tools, Smart Signals, and The Kenakin Brief
On the industry side, Novo Nordisk, Septerna, and Deep Apple advance billion-dollar GPCR programs, while
Other Pages (4)
- Biased agonism at the GLP-1 receptor: from structure to animal models of disease
Sexton is also a co-founder of Septerna Inc. " Patrick Sexton on the web CCeMMP Monash University Dr.
- Ep 89 with Dr. Patrick Sexton
Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.
- Fresh, Fresh, GPCR News ❇ Feb 17 - 23, 2025 | Dr. GPCR Ecosystem
Classified GPCR News Let’s dive into the Classified GPCR News from February 17th to 23rd, 2025 Industry News Septerna Structural Biologist - Confo Therapeutics Associate Director/Director, Platform & Hit-ID Chemistry Lead - Septerna